Anthony Fauci, MD, warns of potential upticks in cases of coronavirus disease 2019 (COVID-19) after holiday travel; the United Kingdom is set to give the first approval to Pfizer, BioNTech’s COVID-19 vaccine candidate; health officials from South Carolina to offer free HIV testing.
Yesterday, the nation’s top infectious disease expert Anthony Fauci, MD, warned of potential upticks in cases of coronavirus disease 2019 (COVID-19) after many Americans refused to adhere to warnings by public health officials against traveling this past holiday week. Reported by The Hill, Fauci urged travelers to be safe when returning home and encouraged them to quarantine if possible and get tested. This past Wednesday, the travel rate reached its highest level since March, with approximately 1.1 million passengers going through airport security.
Reported by Bloomberg, the United Kingdom (UK) could give the first approval to Pfizer Inc. and BioNTech’s COVID-19 vaccine candidate, BNT162b2, as early as this week. The UK has ordered doses of the 2-shot vaccine to immunize approximately 20 million people, although it is noted that it will not be available right away. The first injections are said to potentially take place starting December 7.
As part of World Aids Day on December 1, health officials from South Carolina are offering free HIV testing, as well as testing for other sexually transmitted diseases and Hepatitis C at local health clinics statewide. Reported by The Associated Press, health officials estimate that over 20,000 people in South Carolina are living with HIV, with 1 in 6 noted to be unaware of their status. The South Carolina Department of Health and Environmental Control additionally plans to hold a panel discussion tomorrow, called "Ending the Epidemics" that will include information on preventing the spread of HIV and how those infected live with the virus.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More